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ABSTRACT: G protein-coupled receptors (GPCRs) play a pivotal role in
regulating key physiological events in all animal species. Recent advances in
collective analysis of genes and proteins revealed numerous potential neuro-
peptides and GPCRs from insect species, allowing for the characterization of
peptide−receptor pairs. In this work, we used fluorescence resonance energy
transfer (FRET)-based genetically encoded biosensors in intact mammalian cells
to study the pharmacological features of the cognate GPCR of the type-C
allatostatin (AST-C) peptide from the stick insect, Carausius morosus. Analysis of
multiple downstream pathways revealed that AST-C can activate the human Gi2
protein, and not Gs or Gq, through AST-C receptor (AlstRC). Activated AlstRC
recruits β-arrestin2 independent of the Gi protein but stimulates ERK phosphorylation in a Gi protein-dependent manner.
Identification of Gαi-, arrestin-, and GRK-like transcripts from C. morosus revealed high evolutionary conservation at the G protein
level, while β-arrestins and GRKs displayed less conservation. In conclusion, our study provides experimental and homology-based
evidence on the functionality of vertebrate G proteins and downstream signaling biosensors to characterize early signaling steps of an
insect GPCR. These results may serve as a scaffold for developing assays to characterize pharmacological and structural aspects of
other insect GPCRs and can be used in deorphanization and pesticide studies.
■ INTRODUCTION
Neuropeptides play a central role in vital physiological
processes in vertebrates as well as insects.1 These peptides
exert their biological activities through G protein-coupled
receptors (GPCRs) on their target cells.2 Both human and
insect GPCRs share significant structural homology and may
therefore display common mechanisms of activation.3
Deorphanization and characterization of insect GPCRs
provide a better understanding of insect physiology from the
larval to the adult stage. Within the last two decades,
genome-,4,5 transcriptome-,6,7 and proteome-based8,9 studies
on several insect species identified numerous neuropeptides
and GPCRs, which provided a large database for studying
neuropeptide−receptor pairs. Measuring Ca2+ release in
exogenous systems is a widely used approach to characterize
insect GPCRs. Although this method robustly serves to
characterize the neuropeptide−receptor pharmacology, it is
promiscuous and is placed downstream of G proteins. Thus, it
fails to report the G protein specificity of a receptor.2 At the
vertebrate end of the GPCR spectrum, fluorescence and
bioluminescence resonance energy transfer (FRET and
BRET)-based, genetically encoded biosensors can measure
receptor downstream signaling robustly. These sensors are
extensively used for identifying the pharmacology and signaling
by ligands,10,11 kinetic properties of receptor-mediated signal-
ing,12 as well as deorphanization and characterization of
GPCRs.13 Due to a high degree of homology between human
and insect GPCRs, vertebrate signaling protein-based bio-
sensors may also be functional for characterizing insect
receptors. In accordance, few reports have used such tools to
study insect receptor signaling.14−16
Among insect neuropeptides, allatostatins (ASTs) were
discovered as inhibitors of juvenile hormone (JH) synthesis in
the neuroendocrine glands, namely, C. allata and Corpora
cardiaca.17,18 AST-C inhibits JH synthesis19,20 and modulates
muscle contractility,21 nociception,22 and circadian cycle.23
Analogues of AST-C have been shown to inhibit the feeding
behavior in aphids,24,25 offering a potential use of AST-Cs and
their receptors for the regulation of insect behavior.
AST-Cs bind and activate class A GPCRs, named AST-C
receptors (AlstRCs). The human homologue of AlstRCs is
somatostatin receptors, which primarily inhibit growth
hormone synthesis and secretion,26 and regulate feeding and
drinking behavior27 in mammals. Somatostatin receptors
inhibit adenylyl cyclase (AC) by activating the Gi protein
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and also activate the mitogen-activated protein kinase
pathway.28
The Indian stick insect Carausius morosus (Cmor) is a model
organism used to study motor control29−31 and neuro-
hormone-regulated mechanisms.32−34 Two recent studies
revealed numerous GPCRs and neuropeptides of Cmor,35,36
which offers a great potential for characterizing receptor−
neuropeptide pairs of this species.
Previously, we have identified CmorAlstRC and described
the binding of a Manduca sexta AST-C to it.37 In this study,
using genetically encoded biosensors, we characterize Cmor-
AlstRC with its native agonist in terms of downstream
signaling. Our results describe the ligand-binding domains on
CmorAlstRC that modulate its signaling outcome. We finally
demonstrate that a number of genetically encoded FRET-
based biosensors that report the activation of intracellular
signaling pathways, as well as fluorescently labeled mammalian
G proteins and arrestins, can be used to study the signaling
properties of insect GPCRs.
■ MATERIALS AND METHODS
DNA Constructs. Gβ-2A-cpV-Gγ2-IRES-Gαi2-mTq2
(Gαi2 FRET sensor) and Gq FRET sensors were a gift from
Dorus Gadella38 (Addgene plasmid #69624 and #137810).
Cytoplasmic and nuclear EKAR (Cerulean-Venus) (cytoE-
KAR, nucEKAR) were gifts from Karel Svoboda39 (Addgene
plasmid #18681). Epac-SH187 biosensor was kindly provided by
Kees Jalink.40 pCMV5-α 1a AR plasmid was a gift from Robert
J. Lefkowitz (Addgene plasmid #45760).41
The CamAlstRC in pcDNA3 (CamAlstRC wt) is described
elsewhere.37 The C-terminally EYFP-tagged CamAlstRC
construct (CamAlstRC-EYFP) was generated by amplifying
the CamAlstRC gene using the forward 5′-CCCAAGCT-
TATGTCTGTGGAACAAGTGACG-3′ and the reverse 5′-
TGCTCTAGACACCTGGGTCGGCTGCTG-3′ primers, di-
gesting the PCR product and the β2AR-EYFP using HindIII
and XbaI restriction enzymes, and inserting the digested PCR
product of CamAlstRC in the EYFP-carrying vector backbone.
ECL3293−298Ala and ΔN-term mutants (constructs with and
without the C-terminal EYFP tag) were generated using the
Q5 Site-Directed Mutagenesis Kit (New England Biolabs,
E0554S), using the primers 5′-CCGACACTGCTGCTGATC-
3′ and 5′-AAGCTTGGGTCTCCCTATAG-3′ for the ΔN-
term mutation and 5′- ctgcagctgcGTGCCAGTC-
GAGGGTGTC-3 ′ and 5 ′ - ctgcagctgcTGAGCGC-
CATCTGCGTGA-3′ for the ECL3293−298Ala mutation.
The other constructs used in FRET microscopy experiments
were human Gαi2-ECFP, human Gβ1-wt, bovine Gγ2,
4242 and
human β-arrestin2-ECFP.43
Peptides. Norepinephrine (NE) was purchased from
Sigma-Aldrich (Germany). C. morosus AST-C (with C-
terminal amidation) was custom-synthetized by GenScript.
Drosophila melanogaster pGlu AST-C peptide (Phoenix
Pharmaceuticals, #047-97) and allatostatin 3 (AST-A, Phoenix
Pharmaceuticals, #047-16) were utilized in FRET experiments.
Peptides were dissolved in 0.1% (w/v) bovine serum albumin
(BSA)-containing 1× phosphate-buffered saline (PBS). Fur-
ther, 0.1% (w/v) BSA-containing PBS was used as the vehicle.
Cell Culture and Transfection. HEK293 cells were
cultured in DMEM (PAN Biotech, Germany) containing 4.5
g/L glucose, 10% FBS, 2 mM L-glutamine, penicillin (50 mg/
mL), and Streptomycin (50 mg/mL) at 37 °C in a 5% CO2
incubator. Cells were routinely checked for mycoplasma
contamination using the MycoAlert Mycoplasma Detection
Kit (Lonza, Germany). Cells were seeded in 6 or 10 cm cell
culture dishes prior to transfection. Transfections were
performed using Effectene transfection reagent (QIAGEN,
Germany) according to the manufacturer’s instruction.
For FRET microscopy, HEK293 cells grown in 6 cm dishes
were transfected. For plate reader FRET experiments, HEK293
cells were seeded in 10 cm plates. For all FRET experiments,
the cell culture medium was replaced 16 h after transfection.
FRET measurements were performed 36−48 h after trans-
fection.
Immunocytochemistry and Microscopy. HEK293 cells
were seeded in 6-well plates on poly-L-lysine (PLL, Sigma-
Aldrich, Germany)-coated coverslips and transfected as
described above. The cells were washed once with prewarmed
1X PBS 24 h after transfection and fixed with 1 mL of ice-cold
4% PFA for 20 min at room temperature and then washed
three times with warm 1× PBS. 1× CellMask Deep Red
(Thermo Fisher Scientific) and Hoechst 33342 solution
(Thermo Fisher Scientific) were used according to the
manufacturer’s protocols to label the cell membrane and
nucleus, respectively.
Labeled cells on coverslips were mounted on glass slides
using the VectaShield Antifade Mounting Medium (Vector
Laboratories). Samples were imaged using a Leica TSC SP8
confocal microscopy setup equipped with an HC PL APO
40×/1.30 Oil CS2 objective. Localization of CamAlstRC was
imaged via illumination of EYFP (λex/λem: 514/518−580 nm),
the cell membrane was imaged via CellMask (λex/λem: 649/
655−700 nm), and the nuclei were imaged via Hoechst 33342
stain (UV laser, λex/λem: 405/460−490 nm). Images were
obtained with the LAS X software in a 1024 × 1024 pixel
format, consisting of 4 averaged line scans. The scan speed was
set to 400 Hz, and the pinhole was set to Airy 1.
FRET Microscopy. Transfected cells were reseeded on
PLL-coated 24 mm glass coverslips in 6-well plates. On the day
of measurement, coverslips with transfected cells were placed
in an imaging chamber and maintained in FRET buffer (137
mM NaCl, 5.4 mM KCl, 10 mM HEPES, 2 mM CaCl2, 1 mM
MgCl2 in ultrapure water, pH 7.35). For each coverslip, a
single cell was imaged. During all measurements, the measured
cell was continuously perfused with FRET buffer and/or ligand
solution, using a perfusion system with a valve controller (Ala-
VC3-8SP; ALA Scientific Instruments, Farmingdale). All
measurements were performed on an Axiovert 100 inverted
fluorescence microscope (Zeiss, Germany) equipped with
Plan/Apo N 60×/1.45 Oil (Nikon, Japan). For FRET
measurements, cells were excited at 440 nm (PrecisExcite-
100, CoolLED, U.K., and excitation filter 436/20 nm,
Chroma) for 60 ms at 1 Hertz (Hz) frequency. FCFP (480
nm, CFP emission) and FYFP (535 nm, YFP emission) were
recorded simultaneously at 470/24 nm and 525/39 nm
(Chroma), and a CCD-camera (SPOT Imaging Solutions)
using the VisiView software (Visitron, Germany)
Background fluorescence, YFP emission, and CFP spillover
on the YFP channel were corrected as described previously.44
FRET was calculated as the ratio of corrected YFP and CFP
signals. FRET traces from individual cells were normalized to
the baseline ratio, and each normalized trace was averaged to
show the relative changes in FRET in response to ligands.
FRET-Based Plate Reader Assay. HEK293 cells trans-
fected with CmorAlstRC variants with Gα sensors were
reseeded in black-bottom 96-well plates (Corning) as 75.000
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per well. FRET measurements were performed using a Biotek
Synergy Neo2 Multi-Mode Reader, and data was acquired
using Gen5 software (Biotek, Germany). For the measure-
ments, DMEM was replaced with 90 μL of HBSS. Measure-
ments were performed using dual monochromators for
excitation and emission, and dual PMTs were used for
fluorescence detection. For CFP, excitation and emission
bandwidth were set to 434/20 and 490/20, respectively. FRET
was recorded using the second monochromators, with the
bandwidth settings of 434/20 and 540/25 for excitation and
emission, respectively. The voltage gain for both PMTs was set
to 100. A xenon lamp was set to low-energy mode, read height
was set to 4.5 mm, and read speed was set to normal. Data
points for each well were generated with 90 s intervals. Four
data points per well were measured for the baseline. After the
baseline measurement, cells were stimulated manually with the
ligands using a multichannel pipette, and 5 more data points
were acquired per well. For each concentration, 8 wells were
used and the results were averaged.
FRET was calculated as the ratio of FRET and CFP values
for each data point of each well. FRET changes due to different















Transcript Identification and Phylogenetic Analysis.
Transcripts encoding for C. morosus Gαi, arrestin, and GRK
were searched within Transcript Shotgun Assembly (TSA)
databases using NCBI tblastn tool (https://blast.ncbi.nlm.nih.
gov/Blast.cgi). To search for Gαi, arrestin, and GRK
transcripts, human Gαi2 (UniProtKB: P04899), human β-
arrestin2 (UniProtKB: P32121), and human GRK2 (Uni-
ProtKB: P25098) were used, respectively, as queries. From the
obtained hits, transcripts encoding to proteins with the highest
sequence similarity were selected. The chosen transcripts were
translated to protein, and the obtained protein sequences were
used as a query on NCBI BLASTp to find whether they display
any homology to their insect counterparts.
To generate phylogenetic trees, Gαi, arrestin, and GRK
proteins from various insect and vertebrate species were
obtained using C. morosus Gαi, arrestin, and GRK, respectively,
as query entries on BLASTp, and the protein database was
restricted to selected species. From the results, one isoform of
each protein from each species was selected based on
maximum sequence identity to the query. Phylogenetic trees
were generated using NGPhylogeny tool45 (https://
ngphylogeny.fr/) FastME protocol with default settings.
Statistical Analysis. All data analysis was performed using
GraphPad 5.0 software (San Diego). All data represent the
average of individual recordings with the standard deviation or
the standard error of the mean (SEM) of n individual cells for
FRET microscopy experiments and n individual plates for plate
reader experiments. Concentration−response curves were
generated by fitting a three-parameter Hill equation. An
extra-sum-of-squares F test was performed to compare the
EC50 and Emax parameters of the fitted concentration−
response curves. A statistical difference between these
parameters was accepted as significant at P < 0.05.
■ RESULTS
CmorAlstRC Is Localized to the Plasma Membrane of
HEK293 Cells. To characterize the subcellular localization of
CmorAlstRC, we cloned a construct with the EYFP-encoding
gene fused to the C-terminus of the receptor (CmorAlstRC-
EYFP), expressed it in HEK293 cells, and labeled the nucleus
and cell membrane of these cells to distinguish the receptor
localization. Live-cell confocal microscopy imaging showed
that the fluorescence signal from EYFP was predominantly co-
localized with the cell membrane marker, indicating that
CmorAlstRC mainly resides on the cell membrane (Figure 1).
CmorAlstRC Activates Gαi2 in HEK293 Cells. The
amino acid sequence of a potential CmorAST-C peptide was
previously described as RSYWKQCAFNAVSCF-amide via
transcriptomic and proteomic analyses.35 This peptide is
100% identical with the AST-C peptides from a number of
ant, aphid, and crustacean species (Table S1). To assess
whether this peptide can activate CmorAlstRC, we used
genetically encoded FRET-based biosensors that report the
activation of Gαi, Gαq proteins, as well as the Gαs-mediated
cAMP accumulation.
To measure the Gαi and Gαq activation, we used two FRET
sensors that are based on rearrangements/dissociation between
Gαi/q and Gβγ subunits tagged with donor and acceptor
fluorophores. Upon receptor-mediated G protein activation, a
decrease in FRET is observed (Figure 2A). We co-transfected
HEK293 cells with Gαi2 FRET biosensor
38 and CmorAlstRC
or CXCR4 and measured FRET in 96-well plates. Here,
CXCR4 served as a positive control for Gαi2 activation. For
both receptor + Gαi2 sensor combinations, we observed a
concentration-dependent decrease in FRET, with a pEC50
value of 9.49 ± 0.1 (SD) for CXCR4+CXCL12 and pEC50 =
9.63 ± 0.16 for CmorAlstRC + AST-C (Figure 2B). No
Figure 1. CamAlstRC-EYFP localizes to the cell membrane of
HEK293 cells. Confocal microscopy images of HEK293 cells
transfected with (B) CamAlstR-EYFP (green). (A) Nuclei are stained
with Hoechst 33342 (blue) and (C) cell membrane is stained with
CellMask Deep Red (red). Merged image (D) represents the overlay
of three images of different stainings. The image is representative of
three independent experiments.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c03382
ACS Omega 2020, 5, 32183−32194
32185
response was observed for 1 μM AST-A (Figure S1A) in cells
expressing CmorAlstRC and the Gαi2 sensor. Cells transfected
with an empty vector (pcDNA3), instead of CmorAlstRC, did
not result in any FRET change by AST-C (Figure S1B). On
the other hand, AST-C stimulation of CmorAlstRC did not
activate the Gαq FRET sensor,46 while the norepinephrine
(NE) stimulation of the α1A adrenergic receptor (α1AAR)
induced a concentration-dependent FRET decrease in the Gαq
sensor (Figure 2C).
Next, we used the Epac-SH187 FRET sensor40 to measure
intracellular cAMP levels, as an indirect indicator of Gαs
protein-mediated adenylyl cyclase activation.47 This biosensor
is based on the cAMP-binding Epac1 protein, placed between
donor and acceptor fluorescent proteins. Upon binding to
cAMP, the distance between the fluorophores in the biosensor
increases, resulting in decreased FRET. Therefore, any
decrease in intracellular cAMP would result in an increased
FRET signal (Figure 2D). In cells co-expressing the
CmorAlstRC and Epac-SH187 sensor, AST-C did not induce
any change in the FRET signal, while NE stimulation of the
cells co-expressing the β1 adrenergic receptor (β1AR)
decreased the FRET response (increased the cAMP level) in
a NE concentration-dependent manner (Figure 2E).
Together, these experiments suggest that the AST-C
stimulation of CmorAlstRC can activate the Gαi2 protein,
but not Gαq or Gαs protein, and the Gi activation by AST-C is
only mediated through CmorAlstRC in HEK293 cells.
CmorAlstRC Couples to Gαi2 in HEK293 Cells. After
identifying that CmorAlstRC can activate Gαi2 protein, we
measured whether CmorAlstRC and Gαi2 can directly interact.
Therefore, we performed time-lapse FRET microscopy in live
single HEK293 cells expressing CmorAlstrRC-EYFP and the
C-terminally ECFP-tagged Gαi2 subunits, alongside Gβ1 and
Gγ2, for optimal G protein heterotrimer stoichiometry (Figure
3A). Using a multireservoir perfusion tip, we applied stimulus
and wash-off cycles with different AST-C concentrations. This
experiment revealed a dose-dependent, reversible interaction of
CmorAlstRC with Gαi2 (Figure 3B,C). A fast acquisition mode
(5 Hz) allowed monitoring apparent coupling and dissociation
kinetics between CmorAlstrRC-EYFP and Gαi2-ECFP with 1
μM AST-C (Figure 3D). We obtained an association speed of
τ = 227 (161−303 (Confidence Interval, CI)) ms (Figure 3E),
and dissociation kinetics was τ = 3.8 (3.2−4.7 CI) s (Figure
3F). These findings confirm that CmorAlstRC can rapidly and
reversibly couple with human Gαi2.
CmorAlstRC Inhibits Intracellular cAMP Production.
To corroborate Gi protein preference of CmorAlstRC, we
Figure 2. FRET demonstrates that CmorAlstRC activates Gαi but not Gαq or Gαs. (A) Schematic representation of the working mechanism of
FRET-based G protein activation biosensors. At the resting state, mTurquoise2 (mTq2)-tagged Gα and mVenus (mVen)-tagged Gβγ subunits are
in close proximity (high FRET). Agonist binding to the GPCR activates the G protein biosensor, leading to a decrease in FRET. (B and C) FRET-
based measurement of Gαi2 (B) and Gαq (C) activation in a 96-well format. Concentration−response curves were obtained by stimulation of the
receptors with the different concentrations of their agonists (indicated as Receptor name + Agonist name). Data represents the mean and standard
error of the mean (SEM) from three to four independent plate reader experiments. (D) Working mechanism of the FRET-based Epac-SH187 sensor.
Agonist binding to the GPCR activates the Gαs protein, which in turn activates adenylyl cyclase (AC) that converts intracellular ATP to cAMP
(orange circle). cAMP binding to the Epac domain (black circle) of the Epac-SH187 sensor undergoes a conformational change that induces a
decrease in FRET. (E) Concentration−response relation of AST-C or NE-induced cAMP production. HEK293 cells expressing Epac-SH187 sensor
with CamAlstRC or β1AR were stimulated with increasing concentrations of AST-C or NE. Data represents the average with the SEM of at least
three individual experiments. Data was normalized to the minimum and maximum values observed in cumulative data.
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again used the Epac-SH187 FRET sensor to measure intra-
cellular cAMP. We first expressed CmorAlstRC and Epac-SH187
constructs in HEK293 cells and measured single-cell time-lapse
FRET. Using a perfusion tip, we first continuously applied 3
nM isoprenaline (Iso), a β-adrenoreceptor (β-AR) agonist that
stimulates cAMP production. As a result of this stimulation, we
observed a sharp decrease in FRET, indicating endogenous β-
AR activation, thus intracellular cAMP production. Following
this, we challenged the continuous Iso stimulation with
simultaneous 1μM AST-C superfusion. AST-C was able to
reverse the decrease in the FRET signal, indicating that it
inhibited cAMP production stimulated by Iso (Figure 4A).
We also tested whether the cAMP inhibition assay can be
performed in a microtiter plate format. Cells expressing
CmorAlstRC and Epac-SH187 were pooled in 96-well plates,
pretreated with 1 μM Forskolin (Fsk), which stimulates
adenylyl cyclases (ACs) and increases intracellular cAMP
levels. In these experiments, AST-C concentration-dependently
decreased Fsk-induced cAMP levels (pEC50: 8.72 ± 0.06
(SD)). We repeated this assay in the presence of Pertussis
Toxin (PTx), an inhibitor of Gi protein activity.48 PTx
completely abrogated the AST-C-mediated cAMP inhibition
(Figure 4B). These results supported that AST-C and
CmorAlstRC can inhibit AC activity in a PTx-dependent
manner.
N-Terminus and ECL3 of CmorAlstRC Contribute to
Signaling Efficacy and Potency. Our previous model of
CmorAlstRC with AST-C suggested that the third extracellular
loop (ECL3) and N-terminal domains were important for
ligand binding.37 To test the contribution of these domains to
receptor signaling, we expressed different CmorAlstRC
mutants with the Gαi2 FRET sensor in HEK293 cells and
measured FRET in 96-well plates. On one mutant, the residues
between 293 and 298 were substituted with alanines
(ECL3293−298Ala). On the other mutant, N-terminal 52
residues were deleted (ΔN-term). These mutations did not
cause a remarkable impairment of the receptor localization on
the cell membrane (Figure S2A−D). AST-C stimulation of the
cells expressing the wild-type (WT) CmorAlstRC and the Gαi2
sensor yielded a concentration-dependent response with a
pEC50 value of 9.24 ± 0.08 (SD; Figure 4C). Compared to
the wild-type (WT), the ΔN-term mutant produced a
significantly decreased potency and efficacy in Gαi2 activation.
On the other hand, the ECL3293−298Ala variant also displayed a
lower potency, but the maximum response was similar to that
of the WT receptor (Figure 4C and Table S2A,B).
To further understand the basis of the decreased potency by
mutants, we also tested an AST-C from D. melanogaster
(DmelASTC) on CmorAlstRC. On the 96-well plate format
Gαi2 assay, DmelASTC-induced Gαi2 activation displayed a
lower potency compared to CmorAST-C peptide. On the ΔN-
term variant, we observed a decrease in efficacy, while the
EC50 did not differ when compared to the WT receptor. On
the other hand, the ECL3293−298Ala variant displayed a
significant decrease in potency (Figure 4D) after stimulation
with DmelASTC (Table S2C,D). When we compared the
amino acid sequences of these peptides, we observed a well-
conserved disulfide bond and C-terminal SCF-amide residues
Figure 3. FRET demonstrates that CmorAlstRC is a Gαi-coupling GPCR. (A) Schematic representation of the FRET experiments measuring
interactions between CmorAlstRC (orange bundles) tagged with a C-terminal EYFP (yellow box) and C-terminally ECFP (blue box)-tagged Gαi2
(purple). The upper panel represents the inactive CmorAlstRC. The lower panel represents the ligand (red box)-bound active receptor. (B) A
representative FRET trace of the experiment depicted in (A). A single cell expressing CmorAlstRC-EYFP + Gαi2-ECFP is subjected to superfusion
with varying AST-C concentrations (durations and concentrations are shown above the trace) and washed-out. Data was normalized to the first and
maximum values within the data set. (C) Dose−response relation of CmorAlstRC-EYFP + Gαi2-ECFP interactions as a measure of FRET changes.
Each data point represents the average of maximum responses observed at each concentration. Error bars represent the SD of nine independent
measurements. Dose−response curve-fitting on GraphPad Prism resulted in a pEC50 value of 8.84 ± 0.11 (SD) and an R2 of 0.9186. (D) Kinetic
FRET trace of CmorAlstRC-EYFP + Gαi2-ECFP interactions with high-speed acquisition (50 Hz). Eight independent single-cell traces were
normalized to the minimum and maximum values and averaged to generate the represented trace. (E and F) Zoomed-in view of the trace on (D).
The orange line is the fit generated by ≪Plateau followed by one phase decay≫ function on GraphPad Prism to calculate the tau (τ) values of
receptor-G protein association (E) and dissociation (F). Error bars (gray) represent the SD of nine independent measurements.
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in both peptides, while the similarity is low in the N-terminal
residues (Figure 4E).
CmorAlstRC Recruits Human β-Arrestin2 Independ-
ently of Gαi. We then sought to understand whether
CmorAlstRC activation leads to further classical GPCR
downstream events. Activated receptors are targeted by β-
arrestins, which mediate receptor desensitization. To test β-
arrestin recruitment to CmorAlstRC, we measured FRET in
96-well plates using HEK293 cells transfected with Cmor-
AlstRC-EYFP and human β-arrestin2-ECFP. We observed an
AST-C concentration-dependent increase in FRET with a
pEC50 value of 6.82 ± 0.05 (SD). Also, the presence of PTx
did not change the efficacy or the potency of AST-C notably
(pEC50 = 6.63 ± 0.1; Figure 5A).
To investigate the kinetics of β-arrestin recruitment, we
performed FRET microscopy in single cells expressing
CmorAlstRC-EYFP and β-arrestin2-ECFP. We repeatedly
superfused cells with 10 μM AST-C (Figure 5B) and observed
a slow increase in FRET in the first stimulation, compared to
that of the second one (Figure 5B,C). However, the kinetics of
the FRET decrease upon ligand wash-out was comparable for
both stimulations (Figure 5D).
These results suggest that activated CmorAlstRC interacts
with β-arrestin2 in a Gi protein-independent manner.
CmorAlstRC Induces ERK Phosphorylation in a PTx-
Dependent Manner. MAPK (mitogen-activated protein
kinase)-ERK (extracellular signal-regulated kinase) pathway
activation is a well-established pathway for several GPCRs.49
We tested whether CmorAlstRC activation in HEK293 cells
can induce this pathway. For this purpose, we used the FRET-
based EKAR (extracellular signal-regulated kinase activity
reporter) sensor that reports ERK phosphorylation as an
increase in the FRET signal. This sensor consists of a
phosphorylation domain of Cdc25C that is targeted by
MAPK and a phosphobinding WW domain that is sandwiched
by donor and acceptor fluorophores.39 We investigated this
pathway in two cellular compartments using cytoplasm- and
nucleus-localized EKAR sensors. Using cells in 96-well plates
transfected with CmorAlstRC with either cytoplasmic or
nuclear EKAR, we measured time-dependent changes in FRET
Figure 4. CamAlstRC and its mutants activate Gαi2 distinctly. (A) Time-course FRET microscopy of AST-C-induced cAMP inhibition. HEK293
cells expressing Epac-SH187 sensor with CamAlstRC were stimulated first with isoprenaline, and then AST-C simultaneously, followed by
isoprenaline only. FRET trace represents the average of eight individual experiments from 3 experimental days. The error bar represents the
standard deviation (SD). Data was normalized to the minimum and maximum values observed in the cumulative data. (B) Concentration−
response relation of AST-C-mediated inhibition of Forskolin (Fsk)-induced cAMP production under PTx-treated (red) and -untreated (black)
conditions in HEK293 cells expressing CmorAlstRC and Epac-SH187 sensor in 96-well plates. Concentration−response curve-fitting on GraphPad
Prism resulted in a pEC50 value of 8.72 ± 0.06. Data points represent mean and the SEM from five independent experiments. (C and D) FRET-
based measurement of Gαi2 activation by CamAlstRC in a 96-well format. HEK293 cells expressing Gαi2 FRET sensor with CamAlstRC or its
mutants were stimulated with different concentrations of (C) C. morosus AST-C (CmorAST-C) and (D) D. melanogaster AST-C (DmelASTC). A
concentration−response curve was fitted using GraphPad Prism and the following pEC50 values were obtained with (C) CmorAST-C: WT = 9.24
± 0.08, ECL3293−298Ala = 7.76 ± 0.15, and ΔN-term = 8.4 ± 0.09 and (D) DmelASTC: WT = 8.29 ± 0.12, ECL3293−298Ala = 6.67 ± 0.21, and
ΔN-term = 8.47 ± 0.18. Data represents mean with the SEM from three to four independent plate reader experiments. (E) Sequence alignment of
C. morosus and D. melanogaster AST-C peptides. The alignment was performed using the Clustal Omega tool. (*) indicates fully conserved residues.
(:) indicates residues scoring >0.5 in the Gonnet PAM 250 matrix.
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upon stimulation with AST-C and epidermal growth factor
(EGF). Here, EGF served as a positive control, as it activates
the EGF receptor, which in turn stimulates ERK phosphor-
ylation.39 Both EGF and AST-C increased cytosolic and
nuclear FRET signals within a minute, and the signal peaked
within 5 min after the stimulus (Figure 5E,F). In AST-C
stimulated cells we observed a persistent cytosolic FRET
signal, while it increased only transiently in the nucleus. When
we pretreated the cells with PTx, we did not observe any ERK
phosphorylation by AST-C in either compartment (Figure
5E,F). Together, these results suggest that CmorAlstRC
activation can induce ERK phosphorylation in a PTx-
dependent manner both in cytosolic and in nuclear compart-
ments of HEK293 cells.
Evolutionary Conservation of Gαi, Arrestin, and GRK
Proteins. Since we observed that human Gαi2 and β-arrestin
could couple to phasmid GPCR, we sought to investigate the
conservation of these proteins within various species. To do
this, we first searched the Transcript Shotgun Assembly (TSA)
data of C. morosus, using human Gαi2, β-arrestin2, and GRK2
as queries. We identified one transcript corresponding to a
Cmor Gαi, two corresponding to arrestin, and one
corresponding to GRK. Partial Gαi protein sequence showed
conserved sequences with G proteins from several species on
the putative receptor binding site (Table S3A) and Gβγ
binding site (Table S3B). Using the C. morosus Gαi transcript
in BLASTx as a query, we obtained several insect Gαi and Gαi-
like protein sequences with over 90% similarity. Among these,
Zootermopsis nevadensis (Znev) Gαi displayed the highest
(97.5%) sequence identity. Next, we performed a phylogenetic
analysis between the C. morosus Gαi-like protein and other Gα
subunits from the Z. nevadensis genome. The identified C.
morosus transcript belongs to the same branch as Z. nevadensis
Gαi and is distant from other Gα subunits, suggesting that it
Figure 5. CamAlstRC activation recruits β-arrestin2 to the receptor and stimulates ERK phosphorylation. (A) FRET-based measurement of β-
arrestin2-ECFP recruitment to CamAlstRC-EYFP under PTX-treated (red) and -untreated (black) conditions measured in a 96-well format in
HEK293 cells. The dose−response curve-fitting resulted in pEC50 values as no PTx = 6.81 ± 0.05 (SD) and + PTx = 6.63 ± 0.1. Each data point
represents the average with the SEM of three to six independent plate reader experiments. (B) Cells were repeatedly superfused/washed with AST-
C/buffer to observe the association/dissociation kinetics of β-arrestin2-ECFP recruitment to CamAlstRC-EYFP using FRET microscopy. (C)
Association and (D) dissociation kinetics data was calculated using the data derived from (B). A monoexponential association/decay function was
fit to calculate the tau values for (C) association: first stimulus (blue) = 155.3 s [150−161 CI] and second stimulus (orange) = 13.5 s [12.8−14.3
CI]. The tau values for (D) dissociation were first wash-off (blue) = 17.2 s [23.5−26.4 CI] and second wash-off (orange) = 15.3 s [20.6−23.5 CI].
The FRET trace represents the average with an SD of five different experiments from 3 experimental days. (E and F) 96-well format FRET
measurement of ERK phosphorylation by AST-C. Cells expressing (E) cytosolic EKAR or (F) nuclear EKAR sensor with CamAlstRC were treated
with AST-C at the time point indicated by the dotted line. Epidermal growth factor (EGF) stimulation (black) was used as a positive control.
FRET traces represent the average with SEM of four to five independent plate reader experiments.
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corresponds to a Gαi-coding transcript (Figure 6A). When we
compared the sequence identity of the C. morosus Gαi-like
protein with representative Gαi/o/z/t subunits from verte-
brate and insect species, we obtained the highest similarity
values from Gαi subunits, while the lowest similarities were
observed for Gαt subunits (Figures 6B and S3A). Of note, the
sequence similarity between the C. morosus partial Gαi-like
protein and human Gαi2, which is the subtype we used in our
functional assays, was found to be ∼88.6%. Moreover, these
two proteins displayed an exactly identical C-terminal domain
(Table S3C), which is one of the determinants of Gi coupling
selectivity.50
Using the arrestin protein sequences from the same species
as above, we performed another set of multiple alignments,
including the identified arrestin transcripts from C. morosus.
Compared to the Gαi, C. morosus arrestins showed a lower
sequence identity. Human β-arrestin2 was only 46% identical
with C. morosus Arrestin1 and 42.5% with Arrestin2 (Table
S3D). On the other hand, both C. morosus arrestin transcripts
showed maximum identity with A. aegypti, C. lectularis, and D.
melanogaster arrestins, while the lowest identity was observed
with phosphorestins, S-arrestins, and arrestin-Cs (Figures 6C
and S3B).
The longest transcript encoding a Cmor GRK-like protein
showed more than 80% sequence identity with A. aegypti, C.
lectularis, and Z. nevadensis GRKs. From the human GRKs,
GRK5 (67.2%) appeared to be more similar than GRK2
(36.5%) and GRK3 (37.2%) to the identified C. morosus GRK-
like (Figures 6D and S3C).
Together, the phylogenetic analyses of C. morosus GPCR-
associated signaling proteins showed a divergent similar to
their human homologues. While C. morosus Gαi was highly
conserved, arrestin and GRK from representative insect species
appeared to be less related to their human homologues.
■ DISCUSSION
In this work, we characterized an AlstRC from the stick insect
C. morosus by assessing the downstream signaling events and
receptor−effector interactions.
Using FRET microscopy techniques, we detected that
CmorAlstRC couples to the human Gαi2 even with nanomolar
concentrations of AST-C. At saturating concentrations, this
coupling occurs with ∼200 ms apparent kinetics, which is in
the same kinetic range that was measured for a number of
human GPCR-G protein interactions.51 This coupling led to
human Gαi2 activation, with a matching potency for receptor-
G protein interaction. With a cAMP-detecting FRET sensor
and PTx, we were able to corroborate the specific Gαi protein
activation by CmorAlstRC. As expected, phylogenetic analysis
of Gαi subunits from vertebrates and insects of different orders
exhibited highly conserved patterns of a Gαi subunit,
explaining how CmorAlstRC could couple to and activate
the vertebrate Gi proteins.
Figure 6. Adult C. morosus transcriptome analysis reveals species-specific Gαi, arrestins, and GRK. (A) Protein BLAST-derived phylogenetic tree of
C. morosus Gαi subunit inferred against Z. nevadensis genome. Multiple alignments were automatically generated by BLASTp and the tree was
constructed via the neighbor-joining tree method using the NGPhylogeny tool. Codes starting with XP represent the protein accession number on
NCBI genes. (B, C, and D) Heat-map matrix representation of protein sequence identity comparison (100 = complete sequence homology). A
cross-comparison of Gαi (B), arrestins (C), and GRK (D) proteins from multiple species (Cmor: C. morosus, Hsap: Homo sapiens, Mmus: Mus
musculus, Dmel: D. melanogaster, Apis: Acyrthosiphom pisum, Znev: Z. nevadensis, Aaeg: Aedes aegypti, Clec: Cimex lectularis, and Ccin: Cephus
cinctus) was performed using the Sequence Identity and Similarity tool.
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Our previous observations suggested that both receptor N-
terminus and the 293IFTTP298 motif on the ECL3 are crucial
for AST-C binding.37 First, we confirmed that the membrane
localization of these mutants is not impaired. We observed that
the alanine conversion of the IFTTP motif or the deletion of
the N-terminus of CmorAlstRC decreased the potency of the
agonist-induced Gαi2 activation. These results confirm the
importance of both motifs for CmorAlstRC-mediated Gαi2
signaling. A decreased efficacy on the ΔN-term mutant might
explain how this domain supports the correct orientation of the
ligand on the receptor to achieve maximal receptor activation.
In comparison to the Cmor peptide, a structurally distinct
form of AST-C from D. melanogaster displayed lower potency
in the Gαi2 activation assay. This decrease in EC50 might be
due to the different amino acid compositions of these peptides.
Surprisingly, when we tested Dmel AST-C on the G protein
assay, we observed that this peptide exhibited the same EC50
on the ΔN-term receptor variant but a large decrease in
potency and efficacy on the ECL3293−298Ala mutant. Therefore,
it is possible that the N-terminus of the receptor forms a
different interaction with Dmel peptide compared to the Cmor
peptide, which causes the decreased potency in the Gαi2
activation. On the other hand, the large potency decrease
observed on the ECL3 mutant explains that this domain is
crucial for CmorAlstRC-mediated Gαi2 signaling. Additionally,
this domain may form a hinge point for the other constituents
(N-term and ECL2) of the binding pocket, even with the
alanine substitutions.
Using FRET, we observed that CmorAlstRC recruits human
β-arrestin2 independently of Gi protein coupling. However,
the kinetics of this association is approximately 10 times slower
compared to the human β2AR coupling to β-arrestin2.
43 This
slow kinetics of the arrestin coupling to CmorAlstRC may be
due to the low sequence conservation between vertebrate and
insect arrestins, as shown by our phylogenetic analyses. On the
other hand, repeated stimulus with AST-C increased the speed
of β-arrestin2 recruitment to CmorAlstRC. A similar
acceleration in arrestin coupling by repeated agonist stimulus
was also observed for β2AR.
43 In the case of β2AR, this increase
is a result of the receptor phosphorylation by the prestimuli. It
must be further investigated whether insect receptors interact
with the arrestins in a phosphorylation-dependent manner.
Lastly, CmorAlstRC induces a transient, PTx-sensitive
MAPK-ERK pathway activation in the cytosol and nucleus.
PTx-sensitivity of the ERK activation by CmorAlstRC is in line
with a previous observation suggesting the MAPK-ERK
pathway activation by GPCRs to be G protein-dependent, at
least in HEK293 cells.52 Yet, it should be considered that this
process may be receptor- and cell type-specific.
Altogether, this work delineates the pharmacological features
of the C. morosus AST-C with its cognate GPCR by measuring
multiple signaling pathways and protein−protein interactions.
An important aspect of our work is probing the use of several
FRET-based tools to characterize G protein subtype and
pathway specificity, as well as interactions with downstream
effectors, in pharmacological and kinetic aspects for an insect
GPCR. Therefore, we believe that our work here provides a
selection of assays with great potential to deorphanize and
characterize insect GPCRs and their associated signaling
pathways. Moreover, FRET-based biosensors have been used
in vivo in model animals, such as D. melanogaster14,53 and
Caenorhabditis elegans.54 Recently, a number of novel
biosensors that report direct GPCR activation were shown to
be functional in insects and allowed for real-time imaging of
receptor dynamics, as well as neurotransmitter-mediated
signaling in insects in vivo.55,56 In light of these emerging
technologies, the biosensors that we describe here may also be
suitable for dissecting the spatio-temporal dynamics of
signaling in insects in vivo.
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